Equity Distribution Agreements in the Health Care Equipment & Supplies Industry
18 Contracts & Agreements
- Conformis Inc (1 contract)
- DYNATRONICS CORP (1)
- ENDOLOGIX INC (1)
- GenMark Diagnostics, Inc. (2)
- Nemaura Medical Inc. (1)
- OBALON THERAPEUTICS INC (1)
- ReShape Lifesciences Inc. (1)
- ReWalk Robotics Ltd. (2)
- SeaSpine Holdings Corp (1)
- Sintx Technologies, Inc. (4)
- STRATA Skin Sciences, Inc. (1)
- VOLITIONRX LTD (1)
- ZYNEX INC (1)
- Amendment to Equity Distribution Agreement, dated as of January 10, 2023 by and between SINTX Technologies, Inc., and Maxim Group LLC (Sintx Technologies, Inc., Filed With SEC on January 13, 2023)
- Equity Distribution Agreement, dated May 20, 2022, by and between VolitionRx Limited and Jefferies LLC (VOLITIONRX LTD, Filed With SEC on May 20, 2022)
- Form of Equity Distribution Agreement, dated October 15, 2021, between STRATA Skin Sciences, Inc. and Ladenburg Thalmann & Co. Inc (STRATA Skin Sciences, Inc., Filed With SEC on October 18, 2021)
- Equity Distribution Agreement, dated as of February 25, 2021, by and between SINTX Technologies, Inc. and Maxim Group LLC (Sintx Technologies, Inc., Filed With SEC on February 26, 2021)
- Equity Distribution Agreement, dated as of March 12, 2020, by and among Dynatronics Corporation, Canaccord Genuity LLC and Roth Capital Partners, LLC (DYNATRONICS CORP, Filed With SEC on March 13, 2020)
- Equity Distribution Agreement, dated as of October 29, 2019, by and between Zynex, Inc. and Piper Jaffray & Co (ZYNEX INC, Filed With SEC on October 29, 2019)
- Amendment to Equity Distribution Agreement, dated as of September 12, 2019, by and between SINTX Technologies, Inc. and Maxim Group LLC (Sintx Technologies, Inc., Filed With SEC on September 12, 2019)
- Equity Distribution Agreement, dated August 13, 2019, by and between Endologix, Inc. and Piper Jaffray & Co (ENDOLOGIX INC, Filed With SEC on August 13, 2019)
- Equity Distribution Agreement, dated August 5, 2019, by and between GenMark Diagnostics, Inc. and Canaccord Genuity LLC (GenMark Diagnostics, Inc., Filed With SEC on August 5, 2019)
- Equity Distribution Agreement, dated as of June 4, 2019, by and between SINTX Technologies, Inc. and Maxim Group LLC (Sintx Technologies, Inc., Filed With SEC on June 4, 2019)
- Amendment No. 1 to Equity Distribution Agreement, dated May 9, 2019, between the Company and Piper Jaffray & Co., as Agent (ReWalk Robotics Ltd., Filed With SEC on May 9, 2019)
- Equity Distribution Agreement, dated December 27, 2018, between Obalon Therapeutics, Inc. and Canaccord Genuity LLC (OBALON THERAPEUTICS INC, Filed With SEC on December 27, 2018)
- Equity Distribution Agreement, dated as of October 19, 2018, by and between Nemaura Medical, Inc. and Maxim Group LLC (Nemaura Medical Inc., Filed With SEC on October 19, 2018)
- Equity Distribution Agreement, dated May 11, 2018, by and between SeaSpine Holdings Corporation and Piper Jaffray & Co (SeaSpine Holdings Corp, Filed With SEC on May 11, 2018)
- CONFORMIS, INC. $50,000,000 EQUITY DISTRIBUTION AGREEMENT (Conformis Inc, Filed With SEC on May 10, 2017)
- GenMark Diagnostics, Inc. $30,000,000 EQUITY DISTRIBUTION AGREEMENT (GenMark Diagnostics, Inc., Filed With SEC on July 28, 2016)
- EQUITY DISTRIBUTION PROGRAM $25,000,000 REWALK ROBOTICS LTD. Ordinary Shares EQUITY DISTRIBUTION AGREEMENT (ReWalk Robotics Ltd., Filed With SEC on May 10, 2016)
- ENTEROMEDICS INC. $20,000,000 EQUITY DISTRIBUTION AGREEMENT (ReShape Lifesciences Inc., Filed With SEC on July 31, 2013)
